Barclays raised the firm’s price target on Mettler-Toledo (MTD) to $1,350 from $1,325 and keeps an Overweight rating on the shares as part of a Q3 preview for the life science tools and diagnostics group. The firm views the companies’ end markets as stable with improvements likely going forward. In addition, investment sentiment “feels bottomed” as share valuations have come down, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Mettler-Toledo price target raised to $1,390 from $1,260 at BofA
- Mettler-Toledo price target raised to $1,600 from $1,400 at Citi
- Mettler-Toledo Appoints Pablo Perversi as New Director
- Mettler-Toledo price target raised to $1,230 from $1,210 at Baird
- Mettler-Toledo’s Strong Q2 Overshadowed by Tariff Concerns and Uncertain Future Growth